Phase 4 Multiple Sclerosis Trial, Recruiting NCT07087106 Sponsor: Brigham and Women's Hospital Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Phase 4 Multiple Sclerosis Trial, Recruiting

NCT07087106
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old.
  • You have been diagnosed with multiple sclerosis (MS), including any type such as relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), or primary progressive MS (PPMS), based on recognised diagnostic guidelines — healthy volunteers of a similar age and sex are also being invited to take part.
  • You are willing to have PET and MRI brain scans as part of the study.
  • You are willing and able to give your informed consent to participate.

Who may not be able to join:

  • You have another known brain or nervous system condition, a previous serious head injury, or a history of substance abuse.
  • You have a known mental health condition such as bipolar disorder or schizophrenia.
  • You have other health conditions that would make it unsafe to take part in the study procedures (confirm with trial site).
  • You are pregnant, breastfeeding, trying to become pregnant, or think you may be pregnant.
  • You experience severe anxiety in small or enclosed spaces (claustrophobia).
  • You have a medical implant in your body that is not safe to use near an MRI machine (for example, certain pacemakers or metal implants).
  • You have taken steroid (corticosteroid) medicines within the past four weeks.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Tarun Singhal, MD, MBBS, Brigham and Women's Hospital

Phone: 617-264-3044

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
31 May 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PET measurements in individuals with PMS, RRMS, and healthy controls

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov